Biography
Tucker has advised major biotechnology firms on a broad range of sales and marketing strategy issues related to the biotech industry, with an emphasis on Oncology and Biosimilars. His experience has focused on global quantitative and qualitative primary market research and forecasting. Tucker was one of the founding members of ZS’s Biosimilars Vertical, and he has led over 30 training sessions across North America and Asia on this topic. Tucker holds an M.B.A. with honors from UCLA, and a B.A. with honors in from Stanford University.
Research Interest
Biosimilars, Biologics, Oncology
Biography
Divya Chadha Manek is the Head of Business Development (Commercial) for the NIHR Clinical Research Network (CRN). Divya’s role is to maintain strategic relationships with Global and UK life sciences companies. Divya facilitates key discussions between life sciences industry and the Clinical Research Network. Divya provides advice and works collaboratively with companies on how they are able to tap into the Clinical Research Network services to ensure clinical studies are set up quickly and effi ciently so that they recruit to time and target. Divya also leads on ensuring that the Clinical Research Network is abreast of new study delivery innovations to ensure that the organization is evolving to service life sciences industry requirements.
Research Interest
Pharmaceuticals, Biologics, Biosimilars, Clinical Psychology, Clinical Research, Dementia Care
Biography
Dr. Lutz Hilbrich holds a Medical Degree from the University In Wuerzburg Germany and an MBA from Stern School of Business at NYU, USA. He is currently the Head of the Biosimilars Platform China for Sanofi and was previously second in command for the Biosimilars Business Unit at Boehriger Ingelheim GmbH, Germany. He is experienced in CMC-, Pre-clinical -and Clinical Development but also in Business Development and Market Access Strategies. Besides serving on the Organizing Committee for Asian Biosimilars 2017, he sits on the Biosimilar Advisory Board of the American Conference Institute (ACI).
Research Interest
Biopharmaceuticals, Biologics, Biosimilars, Clinical trials, Drug development